Bioventus (NYSE:BVS), Inc. (NYSE: BVS) is a global medical technology company focused on providing innovative therapeutic solutions to enhance patient care in musculoskeletal health. The company develops, manufactures, and markets a range of products designed to promote bone healing, support joint health, and relieve pain non-invasively. Bioventus leverages biologic and biophysical approaches to deliver effective therapies that aim to accelerate recovery times and improve overall patient outcomes.
Bioventus’s product portfolio includes its flagship EXOGEN® Bone Healing System, an ultrasound-based device indicated for non-union fractures and fracture healing enhancement. The company also offers a suite of orthobiologic injectables, such as hyaluronic acid–based viscosupplements, to support joint lubrication and pain management in patients with osteoarthritis. In addition, Bioventus provides surgical bone graft substitutes and other regenerative medicine products to assist surgeons in addressing complex bone and soft tissue injuries.
With operations spanning North America, Europe, Asia-Pacific, Latin America, and the Middle East, Bioventus serves hospitals, orthopaedic clinics, and ambulatory surgery centers around the world. The company maintains manufacturing and research facilities in the United States and Europe, and has established distribution partnerships to make its therapies accessible across more than 90 countries. This global footprint enables Bioventus to address diverse patient needs and collaborate closely with healthcare providers in various markets.
Founded in 2012 following a spin-off of Smith & Nephew’s biologics division, Bioventus is headquartered in Durham, North Carolina. Since its inception, the company has pursued a strategy of targeted research and development, strategic acquisitions, and clinical collaborations to expand its product offerings and drive adoption of its technologies. Bioventus is led by an experienced management team committed to innovation, quality, and improving patient care in orthopaedics and musculoskeletal medicine.
